|
Quotes & Info
|
| ATHX > SEC Filings for ATHX > Form 8-K on 8-Jan-2013 | All Recent SEC Filings |
8-Jan-2013
Change in Directors or Principal Officers
On January 7, 2013, the Board of Directors of Athersys, Inc. (the "Company"), upon the recommendation of the Compensation Committee of the Board of Directors of the Company, approved the following cash bonuses to the named executive officers of the Company, based on individual performance and achievement of corporate goals in 2012:
Name Title Award Dr. Gil Van Bokkelen Chief Executive Officer $ 107,500 William Lehmann, Jr. President and Chief Operating Officer $ 77,000 Dr. John Harrington Executive Vice President and Chief Scientific Officer $ 77,800 Dr. Robert Deans Executive Vice President, Regenerative Medicine $ 62,300 Laura Campbell Vice President of Finance $ 40,500 |
|
|